Research Topics

Tsunenori Kondo

Summary

Affiliation: Tokyo Women's Medical University
Country: Japan

Publications

  1. Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, et al. Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer. Jpn J Clin Oncol. 2014;44:1233-8 pubmed publisher
    ..This study shows that template-based lymphadenectomy reduced the risk of regional node recurrence in patients with urothelial carcinoma of the renal pelvis and appears to result in improved survival. ..
  2. Kondo T, Nakazawa H, Oya M, Kimura G, Fujii Y, Hatano T, et al. Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib. Jpn J Clin Oncol. 2015;45:274-80 pubmed publisher
    ..In conclusion, the present study confirmed the efficacy of sorafenib in the real-world setting on advanced renal cell carcinoma. ..
  3. Kobari Y, Takagi T, Kondo T, Tachibana H, Iida S, Nishina Y, et al. Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report. World J Surg Oncol. 2015;13:251 pubmed publisher
    ..The patient underwent partial nephrectomy. Pathological findings showed necrosis and hematoma in almost the entire lesion, with a small amount of adipose and muscle tissue. Finally, a fat-poor angiomyolipoma was diagnosed. ..
  4. request reprint
    Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, et al. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment. Target Oncol. 2016;11:605-617 pubmed
    ..0163), and mGPS was an independent predictor of shorter OS (p?=?0.0012). Sarcopenia and mGPS can predict outcomes among patients with mRCC who are receiving first-line sunitinib treatment. ..
  5. Fukuda H, Kondo T, Iida S, Takagi T, Tanabe K. Treatment-related deterioration of renal function is associated with the antitumor efficacy of sunitinib in patients with metastatic renal cell carcinoma. Urol Oncol. 2016;34:338.e1-9 pubmed publisher
    ..98, P = 0.97) was not identified as an independent predictor of OS. The degree of deterioration of renal function might predict the antitumor efficacy of sunitinib in patients with mRCC. ..
  6. Ishihara H, Yagisawa T, Kondo T, Omae K, Takagi T, Iizuka J, et al. Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. Int J Clin Oncol. 2017;22:126-135 pubmed publisher
    ..09, p < 0.0001; OS, hazard ratio 2.32, p = 0.0107). The timing of bTS was an independent predictor of survival in patients with mRCC who received first-line TKIs. ..
  7. Fukuda H, Kondo T, Takagi T, Iizuka J, Nagashima Y, Tanabe K. Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma. Int J Clin Oncol. 2017;22:767-773 pubmed publisher
    ..025) was significantly associated with and the serum neutrophil count (p = 0.067) tended to be associated with the reduction in the IVC thrombus. The clinical benefit of TMT for an IVC thrombus associated with RCC is limited. ..
  8. Ishihara H, Kondo T, Omae K, Takagi T, Izuka J, Kobayashi H, et al. The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol. 2016;46:568-574 pubmed publisher
    ..0001 for both). The magnitude of tumor shrinkage is an independent predictive factor for progression-free survival, and may represent a surrogate marker for overall survival. ..
  9. Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, et al. Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study. Int J Clin Oncol. 2017;22:136-144 pubmed publisher
    ..0001). Multivariate analyses revealed that sarcopenia was an independent predictor of shorter RFS, CSS, and OS (all, p < 0.0001). Sarcopenia was an independent predictor of survival among patients with UCUT who were undergoing RNU. ..

More Information

Publications14

  1. Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, et al. Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer. Int J Clin Oncol. 2017;22:145-152 pubmed publisher
    ..Template-based lymphadenectomy has a therapeutic benefit for treating patients with upper/middle ureteral cancer but not for treating patients with lower ureteral cancer. ..
  2. request reprint
    Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology. 2007;69:265-9 pubmed
    ..To determine the primary site and incidence of lymph node metastases in urothelial carcinoma of the upper urinary tract...
  3. request reprint
    Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol. 2007;178:1212-7; discussion 1217 pubmed
    ..We determined the impact of the extent of regional lymphadenectomy on survival in patients with urothelial carcinoma of the upper urinary tract...
  4. Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nishikawa T, Nakano M, et al. Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. Jpn J Clin Oncol. 2010;40:1173-9 pubmed publisher
    ..The histopathological effect of this treatment was also examined...
  5. Takagi T, Kondo T, Yoshida K, Kobayashi H, Iizuka J, Okumi M, et al. Comparison of Kidney Function in the Early Postoperative Period in Transperitoneal Robot Assisted Laparoscopic Partial Nephrectomy between Anterior and Posterior Renal Tumors - A Propensity Score-Matched Study. J Endourol. 2017;: pubmed publisher